Granted Patent
B2
US 9,242,981 · App. 13/821,149 · Granted Jan 26, 2016
Fused pyrazole derivatives as novel ERK inhibitors
Inventors:
Gerald W. Shipps, Jr. (Stoneham, MA); Yongqi Deng (Newton, MA); Alan B. Cooper (West Caldwell, NJ); Xiaolei Gao (Bridgewater, NJ); Binyuam Sun (Chestnut Hill, MA); James Wang (Westfield, NJ); Liang Zhu (Waltham, MA)
Assignee:
Merck Sharp & Dohme Corp.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Disclosed are the ERK inhibitors of Formula (I): (Formula (I)) and the pharmaceutically acceptable salts thereof. All substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of Formula (I).
Claims (3)
1. A compound which is selected from the group consisting of:
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising at least one compound of claim 1 and a pharmaceutically acceptable carrier.
Assignments (3)
MERGER
Recorded Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Mar 6, 2013
From: SHIPPS, GERALD W., JR.; DENG, YONGQI; COOPER, ALAN B.; GAO, XIAOLEI; SUN, BINYUAN; WANG, JAMES; ZHU, LIANG
To: SCHERING CORPORATION
Reel/Frame 029934/0720 →
CHANGE OF NAME
Recorded Mar 6, 2013
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 029939/0722 →
Continuity (2)
Provisional Application
61383376
· Sep 16, 2010